Navigation Links
Preparative Nondenaturing Gel Electrophoresis to Purify NADP-Specific Glutamate Dehydrogenase From Chlorella, Rev B

Contributed by Philip W Miller, Waltraud I Dunn, and Robert R Schmidt, University of Florida, Dept. Microbiology and Cell Science, Gainesville, FL 32611 USA
Florida Agricultural Experiment Station Serial Number T-00256


Introduction

One of the research goals of this laboratory is to elucidate the pre- and posttranslational mechanisms that regulate both carbon and nitrogen metabolism in plants. Chlorella sorokiniana, a unicellular green alga, has been used extensively as a model system to study enzymes involved in higher plant metabolism. Research in this laboratory has shown that Chlorella sorokiniana possesses seven ammonium inducible, chloroplastic, NADP-specific glutamate dehydrogenase (NADP-GDH) isoenzymes that are regulated by both nitrogen and carbon metabolites (Prunkard et al. 1986). Biochemical, immunochemical, and physical characterization of purified GDH homohexamers revealed that the subunits (α, 55.5 kD; , 53 kD) composing these holoenzymes are nearly identical; however, kinetic characterization of the enzymes showed them to have strikingly different Km values, allosteric properties, and turnover rates (Bascomb and Schmidt 1987). Recent molecular genetic analysis indicates that minor modifications in the primary protein sequences may account for these observed properties. In order to further elucidate the regulation of these isoenzymes, it was necessary to purify to homogeneity a large quantity of active enzyme for polyclonal/monoclonal antibody production and additional protein analysis.

We report here the use of the Model 491 prep cell for the purification of native NADP-GDH protein by nondenaturing PAGE with <2% loss of enzyme activity.


Methods
Glutamate Dehydrogenase Isolation
Chlorella sorokiniana cells were cultured in 29 mM NH4+ medium as previously described (Baker and Schmidt 1963). Approximately 130 g fresh weight cells were harvested by centrifugation and washed two times in 0.01 M Tris-HCl (pH 8.5, 4C). Pelleted cells were resuspended in an equal ratio of breakage buffer (w/v) and ruptured by two passages through a French pressure cell (American Inst. Co.) at 20,000 psi. The cell homogenate was centrifuged at 27,000 x g for 45 min and the supernatant was stored overnight at 20C. Frozen supernatant was thawed and the resulting precipitate was removed by centrifugation at 27,000 x g. Initial purification of the NADP-GDH was accomplished using a modified procedure of Yeung et al. (1981), which employs sequential ion exchange and size exclusion chromatography to remove the bulk contaminating proteins from the cell lysate. Procedural modifications involved the addition of NADP+, which functioned as a stabilizer, to a final concentration of 0.1 mM to the gel filtration buffer and all subsequent buffers. As a final modification, a preparative nondenaturing PAGE step using the Model 491 prep cell was substituted for an expensive NADP-affinity resin step.

Sample Preparation
Following ammonium sulfate precipitation and ion exchange chromatography, size exclusion column fractions, in 10 mM KPO4, 2 mM dithiothreitol (DTT), 0.1 mM NADP+ (pH 6.2), possessing NADP-GDH activity were pooled and concentrated via Diaflo filtration from 17.5 ml to 5 ml. The soluble enzyme was reduced by the addition of DTT to a final concentration of 10 mM and placed in 14,000 MW cutoff dialysis tubing. The concentrated sample was dialyzed at 4C against 28.8 mM Tris, 192 mM glycine, 2 mM DTT (pH 8.4) for 30 min. The dialyzed enzyme preparation was clarified by centrifugation at 20,000 x g for 10 min and was combined with 3 ml of 40% sucrose and 1 ml of 0.02% Bromophenol Blue.

Preparative Nondenaturing Gel Electrophoresis
For preparative nondenaturing gel electrophoresis, a 3 cm high 7% acrylamide (28 acrylamide:0.735 bis-acrylamide, pH 8.8) resolving gel and a 2 cm high 2% acrylamide (1.6 acrylamide:0.4 bis-acrylamide, pH 6.6) stacking gel were cast in the 28 mm ID gel tube of the Model 491 prep cell. The resolving gel was polymerized in 374 mM Tris (pH 8.8) using 140 g/ml ammonium persulfate and 1.12 l/ml TEMED. The stacking gel was polymerized in 39 mM Tris (pH 6.6), 12.7% sucrose using 0.07% riboflavin-5-phosphate (Bio-Rad) and 0.365 l/ml TEMED. Stacking gel polymerization was achieved by exposure to two 5 W fluorescent lights for 45 min. Both gels were cooled as per the Model 491 prep cell instruction manual during the polymerization process. All acrylamide stock solutions were pretreated with AG 501-X8 mixed bed resin to remove any contaminating acrylic acid to prevent in vitro acylation of proteins during the electrophoresis process. The preparative gel was pre-electrophoresed for 10 min at 15 mA constant power in upper/lower gel electrophoresis buffer containing 28.8 mM Tris, 192 mM glycine (pH 8.4, 4C). The elution buffer reservoir was filled with elution buffer comprised of 28.8 mM Tris, 192 mM glycine, 2 mM DTT, and 0.1 mM NADP+ (pH 8.4, 4C). The entire Model 491 prep cell was cooled to 4C during the electrophoresis process by operating the unit in a 4C coldroom. The protein sample, 68 mg total protein in 9 ml of loading buffer, was loaded on top of the stacking gel and electrophoresed for 20 min at 15 mA, and then for an additional 3.5 hr at a constant power of 30 mA using Bio-Rads Model 3000/300 power supply.

Fraction Collection and Analysis
The elution buffer was pumped at a rate of 2 ml/min to a fraction collector and 6 ml fractions were collected. The first fraction after the Bromophenol Blue marker eluted, fraction 1, was collected after 2 hr of electrophoresis. A spectrophotometric assay was used to quantitate the deaminating activity of the NADP-GDH in each fraction. One unit of GDH activity was defined as the amount of enzyme activity required to reduce 1 mol of NADP+/min at 38.5C. NADP-GDH activity was detected in fractions 3568 (Figure 1). The multiple peaks of enzyme activity detected presumably correspond to the multiple isoenzymes of the NADP-GDH.

Analysis of Model 491 Prep Cell Purified NADP-GDH
NADP-GDH containing fractions were combined and the protein concentration was determined by the method of Bradford (1976) using the Bio-Rad protein assay kit with Bio-Rads protein standard II as the standard. Fractions under the peaks were pooled, concentrated, and rinsed with 10 mM KPO4 (pH 6.2), then resuspended in 10 mM KPO4 (pH 6.2), 0.1 mM NADP+ to a concentration of 1 mg/ml for further analysis and storage at 20C. The purity of the protein was determined by Tris-Tricine SDS-PAGE (Schagger and von Jagow 1987) in a 10% polyacrylamide resolving, 3% stacking gel using the Mini-PROTEAN II slab cell (Figure 2). Gels were stained using the Bio-Rad Silver Stain Plus kit.


Results
Chlorella sorokiniana NADP-specific GDH was purified an additional 8.5-fold for a final 375-fold purification using the Model 491 prep cell (see Table). Nondenaturing preparative electrophoresis of the partially purified NADP-GDH sample was performed under conditions determined to be optimal for analytical native slab gel electrophoresis. A total of 11.5 mg of extremely pure GDH protein was recovered with <2% loss of activity during the procedure. The resolution of the nondenaturing gel in the Model 491 prep cell was sufficient to separate multiple peaks of NADP-GDH activity corresponding to the multiple isoenzymes of the GDH isoenzymes. Analytical SDS-PAGE of the final purified product revealed a single 53 kD band corresponding to the NADP-GDH -subunit and detected no contaminating proteins. The highly purified NADP-GDH protein was recovered in sufficient quantity in its native form to allow NH2- and COOH-terminal sequencing, antigen affinity column production, and the production of hightiter polyclonal and monoclonal antibodies.

These results suggest that the Model 491 prep cell system is amenable to large-scale purification of partially purified proteins in their native, active form. The high resolution of this technique, evidenced by its ability to separate closely migrating isoenzymes, should allow separation of multiple isoenzymes for the purpose of kinetic, biochemical, and immunochemical analyses.


Acknowledgment
We thank Dr LO Ingram for the use of the Model 491 prep cell.


References
Baker AL and Schmidt RR, Intracellular distribution of phosphorus during synchronous growth of Chlorella pyrenoidosa, Biochem Biophys Acta 74, 7583 (1963)

Bascomb NF and Schmidt RR, Purification and partial kinetic and physical characterization of two chloroplast-localized NADP-specific glutamate dehydrogenase isoenzymes and their preferential accumulation in Chlorella sorokiniana cells cultured at low or high ammonium levels, Plant Physiol 83, 7584 (1987)

Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem 72, 248254 (1976)

Prunkard DE et al., Effect of different carbon sources on the ammonium induction of different forms of NADP-specific glutamate dehydrogenase in Chlorella-sorokiniana cells cultured in the light and dark, Plant Physiol 81, 413422 (1986)

Schagger H and von Jagow G, Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa, Anal Biochem 166, 368379 (1987)

Yeung A T et al., Purification of an ammonium-inducible glutamate dehydrogenase and the use of its antigen affinity column-purified antibody in specific immunoprecipitation and immunoadsorption procedures, Anal Biochem 110, 216228 (1981)


Diaflo is a trademark of W R Grace & Co.


back to top
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF
2. Detection of Platinum Species in Plant Material by Preparative Isotachophoresis Using the Model 491 Prep Cell, Rev A
3. Preparative Nondenaturing Gel Electrophoresis Used in the Purification of an Esterase Involved in Insecticide Resistance, Rev C
4. Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C
5. Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing
6. A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF
7. Semi Preparative Purification of Proteins
8. A Versatile Power Supply for All Electrophoresis Applications
9. A Multiple Mutation Model System as a Test Development and Training Tool for Denaturing Gradient Gel Electrophoresis
10. Continuous-Elution Electrophoresis for Purification of the Baculovirus-Expressed Coronavirus Structural Proteins, Rev A
11. Detection of K-ras Point Mutations in the Pancreas by Constant Denaturing Gel Electrophoresis Using the DCode System
Post Your Comments:
(Date:3/2/2015)... March 2, 2015  Pfenex Inc. (NYSE MKT: ... development of biosimilar therapeutics, today announced that it ... Healthcare Conference in Miami, FL at the Loews Miami Beach ... officer of Pfenex, will provide an overview of ... 12th at 9:00 am ET. A live audio webcast and ...
(Date:3/2/2015)... 2015 Editor Note: For more ... Moments ago, Analysts Review released new research updates ... (NASDAQ: SSH ), Synergetics USA ... ELOS ), Spectranetics (NASDAQ: SPNC ), and ... single unified platform for investors, to hear about what matters ...
(Date:3/2/2015)... SANTA BARBARA, Calif. , March 2, 2015 ... a biotechnology company developing therapies for autoimmune and ... Trademark Office (USPTO) has issued an important new ... immune system function through the targeting of CLIP. ... the targeted peptide technology underlying VG Life Sciences, ...
(Date:3/2/2015)... Global Stem Cells Group.com ... Shenzhen HANK Bioengineering Co., Ltd. and its Chinese-American ... establish a stem cells training course in the ... 2015. , Shenzhen HANK is a biotechnology company ... microbiologist and virologist, to integrate research, development, production, ...
Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3
... Launch Interactive, Case-Based Website on Cardiovascular Disease for ... Whether it,s a common heart condition or a ... similar patient. That,s why the Society for Cardiovascular ... Inc. (EVF), an IC Sciences Company, today unveiled ...
... iZumi Bio, Inc., a biotechnology company focused on ... technology with the mission of creating new therapeutics ... cells, today announced the appointments of Berta Strulovici, ... Pathak, Ph.D., as vice president of Business Development. ...
... announced successful,completion of the single-day oral dosing part ... patients with its new anti-cancer drug AXL1717,an,insulin-like growth ... the closely related insulin receptor. The study is ... The results showed that a single-day,dosing of AXL1717 ...
Cached Biology Technology:New Website Connects Physicians to Solve Challenging Cases and Share Experiences 2New Website Connects Physicians to Solve Challenging Cases and Share Experiences 3New Website Connects Physicians to Solve Challenging Cases and Share Experiences 4iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 2iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 3Successful Phase I/II Clinical Trial Results From Cancer Patients Treated With Anti-Cancer Drug From Axelar AB 2
(Date:2/24/2015)... Feb. 24, 2015 This report analyzes the worldwide ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle East ... estimates and forecasts are provided for the period 2013 through ... markets. Market data and analytics are derived from primary and ...
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Cepheid to Webcast Upcoming Financial Presentations 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25
... MA.April 25th, 2012Aspera, Inc., creators of next-generation software ... speed, and BGI, the world,s largest genomics research ... have partnered to integrate and deploy the Aspera ... technology with "EasyGenomicsTM", BGI,s latest cloud-based Software as ...
... in state in 1970s; Zoo has monitored for beetle since ... Beetle Conservation; the U.S. Fish & Wildlife Service; the Missouri ... to 600 Zoo-bred American burying beetles for the first ... across the 4,040-acre Wah, Kon-Tah Prairie in Southwest Missouri. ...
... reported to increase risk of developing hepatocellular carcinomas (HCC), independent ... of Hepatology , a journal of the American Association ... 70-fold elevated risk of HCC in those with liver cancer ... hepatitis C (HCV). Liver cancer ranks sixth in ...
Cached Biology News:BGI and Aspera collaborate on high-speed data exchange to advance genome research 2First-ever release of endangered burying beetles in Missouri 2First-ever release of endangered burying beetles in Missouri 3First-ever release of endangered burying beetles in Missouri 4Family history of liver cancer increases risk of developing the disease 2
St. Louis encephalitis Immunogen: St. Louis encephalitis. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse Anti-Gemin2...
5-bromo-2'-deoxyuridine (BrdU) Cell Biology Cell Proliferation Bromodeoxyuridine (BrdU) and Related Products...
Rat CINC-2 alpha/beta Affinity Purified Polyclonal Ab...
Biology Products: